文献
J-GLOBAL ID:201702220921444738
整理番号:17A1964479
HER2陽性乳癌エピジェネティクスにおける最近の進歩:感受性と治療戦略【Powered by NICT】
Recent advances in HER2 positive breast cancer epigenetics: Susceptibility and therapeutic strategies
著者 (6件):
Singla Heena
(Centre for Human Genetics and Molecular Medicine, School of Health Sciences, Central University of Punjab, Bathinda, Punjab 151001, India)
,
Ludhiadch Abhilash
(Centre for Human Genetics and Molecular Medicine, School of Health Sciences, Central University of Punjab, Bathinda, Punjab 151001, India)
,
Kaur Raman Preet
(Centre for Human Genetics and Molecular Medicine, School of Health Sciences, Central University of Punjab, Bathinda, Punjab 151001, India)
,
Chander Harish
(Centre for Human Genetics and Molecular Medicine, School of Health Sciences, Central University of Punjab, Bathinda, Punjab 151001, India)
,
Kumar Vinod
(Centre for Pharmaceutical Sciences and Natural Products, School of Basic and Applied Sciences, Central University of Punjab, Bathinda, Punjab 151001, India)
,
Munshi Anjana
(Centre for Human Genetics and Molecular Medicine, School of Health Sciences, Central University of Punjab, Bathinda, Punjab 151001, India)
資料名:
European Journal of Medicinal Chemistry
(European Journal of Medicinal Chemistry)
巻:
142
ページ:
316-327
発行年:
2017年
JST資料番号:
E0845A
ISSN:
0223-5234
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)